Preeti Salve

Preeti attained her PhD in Pharmacy in 2019 from KLE University (India). Since then, she has developed and patented multiple nanomedicine-based drug delivery systems. At CÚRAM, she is investigating aerosol-based miRNA nanotherapies targeting immune dysregulation in pneumosepsis. She is supervised by John Laffey (University of Galway), and her work bridges nanotechnology, immunology, and pulmonary drug delivery.